Next Article in Journal
Bringing Onco-Innovation to Europe’s Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine
Next Article in Special Issue
The Prognostic Value of Whole-Blood PSMB5, CXCR4, POMP, and RPL5 mRNA Expression in Patients with Multiple Myeloma Treated with Bortezomib
Previous Article in Journal
Molecular and Metabolic Mechanisms Underlying Selective 5-Aminolevulinic Acid-Induced Fluorescence in Gliomas
Previous Article in Special Issue
Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman–Coulter DxH 800 Hematology Analyzer
 
 
Article

Article Versions Notes

Cancers 2021, 13(3), 581; https://doi.org/10.3390/cancers13030581
Action Date Notes Link
article xml file uploaded 2 February 2021 13:23 CET Original file -
article xml uploaded. 2 February 2021 13:24 CET Update https://www.mdpi.com/2072-6694/13/3/581/xml
article pdf uploaded. 2 February 2021 13:24 CET Version of Record https://www.mdpi.com/2072-6694/13/3/581/pdf
article supplementary file uploaded. 2 February 2021 13:24 CET - https://www.mdpi.com/2072-6694/13/3/581#supplementary
article html file updated 2 February 2021 13:25 CET Original file -
article html file updated 3 February 2021 08:17 CET Update -
article html file updated 3 February 2021 10:11 CET Update -
article html file updated 24 July 2022 11:35 CEST Update https://www.mdpi.com/2072-6694/13/3/581/html
Back to TopTop